BDBM50632079 CHEMBL5414092

SMILES Cn1c(=O)ccn(Cc2nnc(s2)-c2ccc(F)c(O)c2F)c1=O

InChI Key InChIKey=KCEBPFZRMWPFAH-UHFFFAOYSA-N

Data  2 KI  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 10 hits for monomerid = 50632079   

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50632079(CHEMBL5414092 | US20250340546, Example 15)
Affinity DataIC50: 3.68nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50632079(CHEMBL5414092 | US20250340546, Example 15)
Affinity DataKi:  4nMAssay Description:Tight binding inhibition of recombinant human full-length C-terminal His-tagged HSD17B13 assessed as inhibition constant by morrison equationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50632079(CHEMBL5414092 | US20250340546, Example 15)
Affinity DataIC50: 5nMAssay Description:Inhibition of recombinant human full-length C-terminal His-tagged HSD17B13 using estradiol and NAD as substrate preincubated for 10 mins followed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50632079(CHEMBL5414092 | US20250340546, Example 15)
Affinity DataIC50: 12.2nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Mus musculus)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50632079(CHEMBL5414092 | US20250340546, Example 15)
Affinity DataIC50: 13.8nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Mus musculus)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50632079(CHEMBL5414092 | US20250340546, Example 15)
Affinity DataKi:  15nMAssay Description:Tight binding inhibition of recombinant mouse full-length C-terminal His-tagged HSD17B13 assessed as inhibition constant by morrison equationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
Target17-beta-hydroxysteroid dehydrogenase 13(Mus musculus)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50632079(CHEMBL5414092 | US20250340546, Example 15)
Affinity DataIC50: 55nMAssay Description:Inhibition of recombinant mouse full-length C-terminal His-tagged HSD17B13 using estradiol and NAD as substrate preincubated for 10 mins followed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50632079(CHEMBL5414092 | US20250340546, Example 15)
Affinity DataIC50: 76nMAssay Description:Inhibition of recombinant human full-length C-terminal His-tagged HSD17B13 expressed in HEK293 cells using estradiol as substrate preincubated for 30...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
Target17-beta-hydroxysteroid dehydrogenase 13(Mus musculus)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50632079(CHEMBL5414092 | US20250340546, Example 15)
Affinity DataIC50: 2.42E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

TargetEstradiol 17-beta-dehydrogenase 11(Homo sapiens)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50632079(CHEMBL5414092 | US20250340546, Example 15)
Affinity DataIC50: 3.26E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent